Results 141 to 150 of about 22,482 (226)

Use of Aflibercept to Treat Choroidal Neovascularization Secondary to Choroidal Osteoma in a 7-Year-Old Child: A Multimodal Imaging Case Report. [PDF]

Case Rep Ophthalmol Med
Altalhi A, Alqurashi A, Albassam M, Alyahya A.   +3 more
europepmc   +1 more source

Artificial Intelligence-Assisted Analysis of Retinal Pigment Epithelium Tears in Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept (2 mg and 8 mg) and Faricimab: A Single-Centre Retrospective Case Series. [PDF]

J Clin Med
Eggarter V, Ruscitti L, Ascioti N, Bonanata M, Peyla A, Simona F, Menghini M, Grimaldi G.   +7 more
europepmc   +1 more source

Faricimab versus Aflibercept for Discharge and Readmission in Neovascular Age-Related Macular Degeneration: A Lesion-Type Stratified, Real-World UK Analysis. [PDF]

Clin Ophthalmol
Singh Bhangu J, Swarnkar PK, Stewart C, Rifat M, Khalid S, Al-Janabi A, Awad MH, Williams GS.   +7 more
europepmc   +1 more source

Letter to the Editor Regarding "Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials". [PDF]

Ophthalmol Ther
Panos GD.
europepmc   +1 more source

Effects of Intravitreal Anti-VEGF Therapy on Conjunctival Flora and Antibiotic Resistance in Age-Related Macular Degeneration. [PDF]

Microorganisms
Gündüz A, Ekici Gök Z, Evren Ö.
europepmc   +1 more source

Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. [PDF]

Clin Ophthalmol
Mansour HA, Eandi CM, Pichi F, Foster RE, Charbaji SA, Chakraborty D, Ellabban AA, Belotto S, Abu Serhan H, Magnin S, Lopez-Guajardo L, Pérez-Salvador García E, Schwartz SG, Stewart MW, Rey A, Jürgens I, Casella AMB, Upadhyay A, Sheth JU, Lima LH, Sinawat S, Abengoechea S, Capella MJ, Viver Oller S, Elizalde J, Kheir WJ, Mammo D, Barbosa GCS, Villegas VM, Desai A, Tripathy K, Bala S, Mohan N, Elnahry AG, Uwaydat SH, Cherfan DG, Parodi MB, Mansour AM.   +37 more
europepmc   +1 more source

Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis

Eye
Valentina Sarao, Daniele Veritti, Francesco Bonini, Asia Amelia Martin, P. Lanzetta   +4 more
semanticscholar   +1 more source

Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg. [PDF]

Ophthalmol Ther
Sherif MZ, Teo KYC, Lai TYY, Chan HH, Fenner BJ, Lee WK, Cheung CMG.   +6 more
europepmc   +1 more source

Dynamic changes in aqueous humor cytokines and OCTA parameters during aflibercept loading in treatment-naive neovascular age-related macular degeneration. [PDF]

Front Med (Lausanne)
Gui C, Chen X, Liu H, Dong J, Zhang Q, Gao Y, Peng Q.   +6 more
europepmc   +1 more source

Eye Drop Development of Anti-VEGF Therapeutics by Ocular Penetrating Carrier to the Posterior Region of the Eye. [PDF]

Transl Vis Sci Technol
Chiueh VC, Lee LL, Tau S, Luu M, Park JH, Lee T.   +5 more
europepmc   +1 more source